Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Although a fairly large proportion of patients have reported a number of side effects, particularly at the gastrointestinal level (nausea, vomiting, diarrhoea), these side effects tend to diminish over time and adherence to treatment remains high, with about 5% of patients discontinuing treatment due to side effects
This material is supplied specifically for laboratory research use only (RUO) in the fields of endocrinology, metabolism, and growth hormone biology
Preserves Lean Muscle: As you lose weight, exercise ensures that youre losing fat and not muscle, keeping you toned and fit
The trial data are available at PubMed (PMID: 37530551), providing peer-reviewed evidence for the retatrutide weight-loss results
Additional safety considerations include: Acute pancreatitis risk : Patients should be monitored for severe abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Dehydration and acute kidney injury : Particularly with gastrointestinal side effects Hypoglycemia : When used with insulin or sulfonylureas in patients with diabetes Diabetic retinopathy complications : Particularly with semaglutide in patients with pre-existing retinopathy Patients with hypothyroidism should undergo thyroid function monitoring when starting weight loss injections
Experimental Models: Supports research on soft tissue, tendons, and cellular pathways related to tissue maintenance
US$ 24.15
US$ 20.25
US$ 22.99
US$ 25.26
US$ 25.31
